Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Baird Medical Investment Holdings Limited (BDMDW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/27/2025: BDMDW (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -66.67% | Avg. Invested days 27 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/27/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta -0.7 | 52 Weeks Range 0.02 - 0.20 | Updated Date 06/3/2025 |
52 Weeks Range 0.02 - 0.20 | Updated Date 06/3/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 37.96% | Operating Margin (TTM) 38.74% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 10638416 |
Shares Outstanding - | Shares Floating 10638416 | ||
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Baird Medical Investment Holdings Limited
Company Overview
History and Background
Baird Medical Investment Holdings Limited is a company focused on medical investments and healthcare solutions. Specific founding year and detailed milestones are not publicly and readily available.
Core Business Areas
- Medical Investments: Investment in medical technology companies, healthcare facilities, and pharmaceutical development projects.
- Healthcare Solutions: Providing healthcare-related services, including consultation, management, and technology integration.
Leadership and Structure
Information on the specific leadership team and organizational structure is not readily available in public sources.
Top Products and Market Share
Key Offerings
- Medical Technology Investments: Investment in companies developing medical devices, diagnostic tools, and healthcare IT solutions. Market share data is not publicly available. Competitors include other investment firms specializing in medical technology such as OrbiMed Advisors, NEA, and Kleiner Perkins Caufield & Byers.
- Healthcare Management Services: Providing management and consulting services to healthcare providers. Market share data is not publicly available. Competitors include large consulting firms such as McKinsey, Boston Consulting Group, and Deloitte.
Market Dynamics
Industry Overview
The healthcare investment industry is growing, driven by technological advancements, aging populations, and increasing healthcare expenditures. Significant competition exists in this sector.
Positioning
Baird Medical Investment Holdings Limited aims to capitalize on growth opportunities by strategically investing in and supporting innovative healthcare companies. Without detailed information, pinpointing their specific competitive advantage is challenging.
Total Addressable Market (TAM)
The global healthcare market is estimated to be trillions of dollars. Baird Medical Investment Holdings Limited's position relative to this TAM is dependent on its specific investment portfolio and market penetration.
Upturn SWOT Analysis
Strengths
- Investment expertise in healthcare sector
- Potential access to innovative technologies
- Network within the healthcare industry
Weaknesses
- Limited publicly available information
- Reliance on successful investments
- Potential lack of diversification
Opportunities
- Growing demand for healthcare technologies
- Expansion into new geographic markets
- Partnerships with established healthcare providers
Threats
- Economic downturn affecting investment returns
- Regulatory changes in the healthcare industry
- Increased competition from other investment firms
Competitors and Market Share
Key Competitors
- OrbiMed Advisors (Private)
- NEA (Private)
- Kleiner Perkins Caufield & Byers (Private)
Competitive Landscape
Baird Medical Investment Holdings Limited operates in a competitive landscape against larger private equity firms with greater assets under management. Their strengths would likely lie in specific areas of expertise or niche markets. Detailed competitive advantage requires more specific information.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends cannot be assessed due to limited data availability.
Future Projections: Future growth projections are unavailable without financial data and strategic plans.
Recent Initiatives: Specific recent initiatives undertaken by Baird Medical Investment Holdings Limited are not publicly known.
Summary
Baird Medical Investment Holdings Limited invests in the growing healthcare sector. Lack of publicly available information limits a thorough analysis of its strengths and weaknesses. The company's success depends on strategic investments and navigating the competitive landscape. Monitoring industry trends and regulatory changes is crucial.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- General News Sources
Disclaimers:
The information provided is based on limited publicly available data and should not be considered financial advice. The analysis is subject to change as more information becomes available.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Baird Medical Investment Holdings Limited
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2024-10-02 | Chairwoman of the Board of Directors & CEO Ms. Haimei Wu | ||
Sector Healthcare | Industry Medical Devices | Full time employees 143 | Website https://bairdmed.com |
Full time employees 143 | Website https://bairdmed.com | ||
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research and development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. It offers microwave ablation apparatus and needles, as well as microwave ablation apparatus approved for the treatment of live cancer and thyroid nodules, long microwave ablation needles, and fine microwave ablation needles through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.